Malignant neoplasm of breast
|
0.550 |
GeneticVariation
|
disease |
BEFREE |
Thus, we set out to identify novel single nucleotide polymorphisms (SNPs) within SRC-1 (NCoA1), SRC-3 (NCoA3, AIB1), NCoR (NCoR1), and SMRT (NCoR2), and test the most promising SNPs for associations with breast cancer risk.
|
20003447 |
2009 |
Breast Carcinoma
|
0.550 |
GeneticVariation
|
disease |
BEFREE |
Thus, we set out to identify novel single nucleotide polymorphisms (SNPs) within SRC-1 (NCoA1), SRC-3 (NCoA3, AIB1), NCoR (NCoR1), and SMRT (NCoR2), and test the most promising SNPs for associations with breast cancer risk.
|
20003447 |
2009 |
Polycystic Ovary Syndrome
|
0.210 |
GeneticVariation
|
disease |
BEFREE |
Two hypermethylated CpG sites in the PPARG1 promoter and five hypomethylated CpG sites in the NCOR1 promoter were observed only in HA PCOS women (P < 0.01 to P < 0.0005).
|
22349439 |
2012 |
Forced expiratory volume function
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries.
|
30804560 |
2019 |
Forced expiratory volume function
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Sixteen new lung function signals identified through 1000 Genomes Project reference panel imputation.
|
26635082 |
2015 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Tumor analysis revealed two mutations: a TP53 missense mutation c.481G>A (p. Ala161Tyr) and NCOR1 nonsense mutation c.6052C>T (p. Arg2018*).
|
30039904 |
2018 |
Vital capacity
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries.
|
30804560 |
2019 |
Joint laxity
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
C-reactive protein measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders.
|
30388399 |
2018 |
Low density lipoprotein cholesterol measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci.
|
23063622 |
2012 |
Thyroxine measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide analyses identify a role for SLC17A4 and AADAT in thyroid hormone regulation.
|
30367059 |
2018 |
High density lipoprotein measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci.
|
23063622 |
2012 |
Thin skin
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Developmental delay (disorder)
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Serum HDL cholesterol measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci.
|
23063622 |
2012 |
Serum LDL cholesterol measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci.
|
23063622 |
2012 |
Global developmental delay
|
0.100 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Body mass index
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Body mass index
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry.
|
30239722 |
2019 |
Hyperlaxity
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Arteriosclerosis
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
We demonstrate that myeloid cell-specific deletion of nuclear receptor corepressor 1 (NCOR1) aggravates atherosclerosis development in mice.
|
31529020 |
2020 |
Atherosclerosis
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
We demonstrate that myeloid cell-specific deletion of nuclear receptor corepressor 1 (NCOR1) aggravates atherosclerosis development in mice.
|
31529020 |
2020 |
Childhood Leukemia
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
AML1-ETO-W692A loses N-CoR binding at NHR4, displays attenuated transcriptional repression ability and decreased cellular dysregulation, and promotes leukemia in vivo.
|
23426948 |
2013 |
leukemia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
AML1-ETO-W692A loses N-CoR binding at NHR4, displays attenuated transcriptional repression ability and decreased cellular dysregulation, and promotes leukemia in vivo.
|
23426948 |
2013 |
Lung Neoplasms
|
0.010 |
GeneticVariation
|
group |
BEFREE |
In our article, by using an in silico approach, we evaluate the mutational status of NCOR1 in breast and lung tumors.
|
30485330 |
2018 |